Galectin Therapeutics | GALT - Equity Capital And Reserves

Stock Price
3.02
Daily Change
0.05 1.68%
Monthly
-3.21%
Yearly
106.85%
Q1 Forecast
2.88

Galectin Therapeutics reported $-83.87M in Equity Capital and Reserves for its fiscal quarter ending in June of 2024.





Equity Capital And Reserves Change Date
AbbVie USD -3.27B 628M Dec/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Galectin Therapeutics USD -83.87M 11.06M Jun/2024
Gilead Sciences USD 22.62B 1.16B Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Incyte USD 5.17B 516.28M Dec/2025
Merck USD 51.85B 2.79B Sep/2025